期刊文献+

进口头孢他美酯片剂健康人体药代动力学研究 被引量:2

Pharmacokinetics of cefetamet pivoxil in normal Chinese
下载PDF
导出
摘要 目的:本文报道瑞士产头孢他美酯片剂在我国健康志愿者人体药代动力学研究结果。方法:采用反相高效液相色谱法测定名志愿者口服盐酸头孢他美酯片剂后的血药浓度,椐程序计算有关药动学参数。12 3P87 结果:该制剂的 t、 (Ke) Tpeak、Cmax和分别为、、、·,药时曲线符合一室开放模型。AUC2.3h2.79h2.17mg/L18.69(mg/L)h结论:口服头孢他美500mg酯后的血药浓度高于大多数常见致病菌的,其消除半衰期较长,一日两次给药即可。 Objective: The pharmacokinetics of cefetamet pivoxil was determined after a single 500mg oral dose given to twelve male volunteers. Methods: The concentrations of drug-serum samples were measured by high performance liquid chromatography (HPLC). Results: The results showed that the serum concentration-time profile conformed to an one-compartment open model. The maximum serum level was 2.17mg/L, and was attained ·2.79h after administration. The mean serum elimination half-life was 2.34h. The AUC was 18.96 (mg/L)h. Conclusion: The serum concentration after a single dose of 500mg is above the MIC for most of the commonly encountered pathogens. The elimination half-life is long enough, so cefetamet pivoxil may be administrated twice a day.
出处 《重庆医科大学学报》 CAS CSCD 2002年第2期193-195,共3页 Journal of Chongqing Medical University
关键词 头孢他美酯 高效液相色谱法 药代动力学 血药浓度 Cefetamet pivoxil HPLC analysis Pharmacokinetics Blood concentration
  • 相关文献

参考文献4

  • 1[1]Koup JR, Dubach UC, Brand R, et al. Pharmacokinetics of cefetamet (RO 15-8074) and cefetamet pivoxil (Ro 15-8075)after intravenous and oral doses in humans [J]. Antimicrob Agents Chemother, 1988; 32(4): 573-579.
  • 2[2]Tam Yk, Kneer J, Doubach UC, et al. Pharmacokinetics of cefetamet pivoxil (Ro 15-8075) with ascending oral doses in normal healthy volunteers [J]. Antimicrob Agents Chemother,1989; 33(6): 957-959.
  • 3[3]Lode H, Fassbender M, Schaberg T, et al. Comparative pharma cokinetics of the new oral cephalosporins [J]. Drugs,1994; 47(s 3): 10-20.
  • 4[4]Bryson HM, Brogden RN. Cefetamet pivoxil-a review of its antibacterial activity, pharmacokinetic properties and therapeutic use[J]. Drugs, 1993;45(4):589-621.

同被引文献13

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部